Nutriband (NASDAQ:NTRBW) Stock Price Down 0.9% – Time to Sell?

Nutriband Inc. (NASDAQ:NTRBW)’s share price fell 0.9% on Tuesday . The company traded as low as $1.12 and last traded at $1.12. 100 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 2,391 shares. The stock had previously closed at $1.13.

Nutriband Trading Down 0.9%

The firm’s 50-day moving average price is $1.42 and its 200-day moving average price is $1.63.

Institutional Investors Weigh In On Nutriband

A hedge fund recently bought a new stake in Nutriband stock. Empery Asset Management LP acquired a new stake in Nutriband Inc. (NASDAQ:NTRBW) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband comprises approximately 0.1% of Empery Asset Management LP’s investment portfolio, making the stock its 20th largest position.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.